opnurasib
novartis
['jdq443', 'lung', 'nsclc', 'lcsm,(-blcsm)', 'sclc']
#asco23 #lungcancer #lcsm dr. rajwanth veluswamy, tisch cancer institute
a phase ii trial of jdq443 in kras g12c-mutated nsclc with pd-l1 expression &lt;1% or pd-l1 expression 1% and an stk11 co-mutation.
abstract: tps9158 | poster bd #: 136b 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.